Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aleafia Health Inc (OP: ALEAF )

0.0676 -0.0013 (-1.89%)
Streaming Delayed Price Updated: 3:04 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 54,237
Open 0.0675
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0689
Today's Range 0.0675 - 0.0700
52wk Range 0.0516 - 0.3970
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aleafia Health Reaffirms Revenue Guidance, Implements $6.7 Million In Annualized Cost Savings
Aleafia Health Inc. (TSX:AH) (OTCQX: ALEAF) reaffirmed its guidance with an announcement that it expects to achieve between $53 million and $63 million in net revenue in the current fiscal year. 
Via Benzinga
The Canadian Cannabis Report - Monday, March 28
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets

Performance

YTD
-41.72%
-41.72%
1 Month
-17.96%
-17.96%
3 Month
-24.38%
-24.38%
6 Month
-45.13%
-45.13%
1 Year
-79.31%
-79.31%

More News

Read More
The Canadian Cannabis Report- Monday, March 21
Via Talk Markets
The Canadian Cannabis Report- Monday, Feb. 21
Via Talk Markets
Will Aleafia Reach Its Revenue Goals With Convertible Debt Being 'Pushed Back'? Analyst's Thoughts Post Q4 Earnings
Via Benzinga
Aleafia Health Provides Further Update On Its Convertible Debt
Via Benzinga
The Canadian Cannabis Report- Monday, Feb. 14
Via Talk Markets
The Canadian Cannabis Report- Monday, Jan. 24
Via Talk Markets
The Canadian Cannabis Report - Monday, Jan. 10
Via Talk Markets
The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10%
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Nov. 15
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
Via Benzinga
Topics Cannabis
Exposures Cannabis
Excitement Brewing in D.C., $ACRHF Trending Up — Cannabis Daily November 11, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Sept. 27
Via Talk Markets
Topics Cannabis
Exposures Cannabis
11 Cannabis Stocks That Have Moved Significantly In September
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Only 2 of These 11 Cannabis Stocks Have Traded Higher in September
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Aug. 30
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: $1.25B+ In Financings And M&A, Tilray, KushCo, New York And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aleafia Health Closes $10M Credit Facility, Improves Financial Flexibility To Continue Sales Growth
Via Benzinga
The Canadian Cannabis Report - Monday, August 23
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Bearish Wave Dumps Marijuana Stocks - GrowGeneration Sundial Growers And Aurora Cannabis Among Top Cannabis Movers For Today - Tilray Down By 6%
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: An Earnings Avalanche, Biden's Clemency Plans, Cuomo's Resignation And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aleafia Health Reveals 53% QoQ Spike In Q2 2021 Cannabis Net Revenue
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Movers & Shakers: Khiron, Aleafia, Green Scientific Labs, 4Front Ventures, Halo Collective, Kiva Sales & Service, Sharp Capital Advisors, Simplifya, Organigram
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray, Aurora, Sundial, Hexo Q2 Market And Sales Trends, Cantor Fitzgerald Projects Stronger Q3
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.